Medical News

RSS

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

Human umbilical cord blood cells (HUCB) used to treat cultured rat brain cells (astrocytes) deprived of oxygen appear to protect astrocytes from cell death after stroke-like damage, reports a team of researchers from the University of South Florida (USF) Department of Neurosurgery and Brain Repair.

25 Aug 2010

Adoption of standby intra-aortic balloon pump strategy during high-risk PCI needed: Study

High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure did not experience a significantly lower overall rate of events such as heart attack, revascularization or death, according to a study in the August 25 issue of JAMA.

25 Aug 2010

Inspire Pharmaceuticals, Allergan sign amended agreement for ophthalmic formulations

Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.

25 Aug 2010

First Edition: August 25, 2010

In today's headlines, news about a Medicare change that may cause an estimated three million seniors to switch their drug coverage.

25 Aug 2010

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.

25 Aug 2010

ZymoGenetics completes enrollment in Phase 2b PEG-IFN lambda clinical trial

ZymoGenetics, Inc. today announced enrollment has been completed in the Phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection.

25 Aug 2010

Warner Chilcott receives FDA response to citizen petition for ASACOL and ASACOL HD products

Warner Chilcott plc today announced that it has received the Food and Drug Administration's response to a citizen petition it had filed regarding its ASACOL and ASACOL HD products.

25 Aug 2010

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Total Nutraceutical Solutions, Inc., announced that it has completed a research study comparing the therapeutic effect of single nutrient forms of synthetic Vitamin D3 and D2 versus natural Vitamin D2 within a whole food. The study focused on the control of Paraquat induced oxidative stress/biologic death.

25 Aug 2010

Kindred subsidiaries to acquire 5 long-term acute care hospitals from Vista Healthcare

Kindred Healthcare, Inc. today announced that its subsidiaries have signed a definitive agreement to acquire five long-term acute care ("LTAC") hospitals from Vista Healthcare, LLC for a purchase price of $180 million in cash.

25 Aug 2010

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

The WHO "has granted prequalification status to Pfizer Inc.'s children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product," the Associated Press reports (8/23).

25 Aug 2010

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.

25 Aug 2010

Experts unveil preventive measures for Lyme disease

Lyme disease is not only a potentially serious disease, but one that often is missed by physicians, which makes prevention more important. The only way to get Lyme disease is from the bite of an infected deer tick. The best prevention, then, is to avoid deer and their ticks.

25 Aug 2010

USN and St. Rose introduce new accelerated bachelor's degree in nursing

The University of Southern Nevada and St. Rose Dominican Hospitals have partnered to help shape Nevada's workforce by preparing qualified registered nurses to meet the state's future healthcare demand. As a result, career seekers and career changers who already have a bachelor's degree can become a registered nurse in 14 months through a new accelerated bachelor's degree in nursing (ABSN).

25 Aug 2010

MRI and MR spectroscopy determine internal fat distribution: Study

Why is it that some people lose weight and body fat when they exercise and eat less and others don't. German researchers say MRI and magnetic resonance (MR) spectroscopy can provide the answer and help predict who will benefit from lifestyle changes.

25 Aug 2010

Current egg recall highlights shortcomings in food safety system, sets up call for Senate action in September

Politico: Problems in the nation's response to the current salmonella outbreak and the resulting recall of 600 million eggs is related to the Senate's year-long stall of pending food safety legislation, according to consumer groups and experts. "The House approved its version of the food safety bill in July 2009 — that was more than 60 recalls of Food and Drug Administration regulated products ago, according to a report by the Make Our Food Safe Coalition.

25 Aug 2010

U.S. DOE awards Dynasil 7 Phase-II SBIR grants totaling $6.2 million

Dynasil Corporation of America today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc, to develop its state of the art nuclear sensors and instruments.

25 Aug 2010

FDA releases guidance on federal nutrition labeling requirements

The U.S. Food and Drug Administration today released two documents that outline steps to help chain restaurants comply with new federal nutrition labeling requirements.

25 Aug 2010

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 data at this year's Joint International NGM Meeting on Saturday, August 28, 2010.

25 Aug 2010

MedAssets to offer Prodigo's e-procurement marketplace solutions

To improve efficiency and contract compliance for hospitals and other health care providers, Prodigo Solutions LLC today announced an exclusive agreement with MedAssets to offer its customers Prodigo's electronic-procurement marketplace solutions.

25 Aug 2010

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that some surveyed physicians indicate that they will decrease their overall prescribing of long-acting beta2 agonists (LABA)/inhaled corticosteroids (ICS) combination therapies over the next 12 months for the treatment of asthma in response to the U.S. Food and Drug Administration's new safety controls for LABA-containing medications.

25 Aug 2010

Medical News

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

Adoption of standby intra-aortic balloon pump strategy during high-risk PCI needed: Study

Inspire Pharmaceuticals, Allergan sign amended agreement for ophthalmic formulations

First Edition: August 25, 2010

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

ZymoGenetics completes enrollment in Phase 2b PEG-IFN lambda clinical trial

Warner Chilcott receives FDA response to citizen petition for ASACOL and ASACOL HD products

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Kindred subsidiaries to acquire 5 long-term acute care hospitals from Vista Healthcare

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

Experts unveil preventive measures for Lyme disease

USN and St. Rose introduce new accelerated bachelor's degree in nursing

MRI and MR spectroscopy determine internal fat distribution: Study

Current egg recall highlights shortcomings in food safety system, sets up call for Senate action in September

U.S. DOE awards Dynasil 7 Phase-II SBIR grants totaling $6.2 million

FDA releases guidance on federal nutrition labeling requirements

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

MedAssets to offer Prodigo's e-procurement marketplace solutions

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News